News
Filter
-
Dementia Consortium funds Manchester based team targeting immune system in search for new dementia treatments
-
MRC Technology licenses antibody to Newsummit Biopharma for development of Hepatitis C virus infection therapeutic
-
MRC Technology joins project UTILE to enable medical breakthroughs from European funded research
-
MRC Technology appoints Steve Visscher as new trustee
-
MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies
-
MRC Technology invests £7 million to expand its diagnostics research capability in Scotland
-
Putting patient wellbeing and collaboration at the heart of what we do
-
Rethinking drug research, before it’s too late
-
MRC Technology, UCB and the University of Leicester combine research excellence and expertise to evolve drug discovery
-
New collaboration to explore novel treatments for respiratory diseases
-
MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital
-
MRC Technology and Keio University to collaborate on drug discovery
